Clinical Trial Update: NOLAN: Naproxen or Loratadine and Neulasta [Phase 2]

View source ↗

Summary

Phase 2 trial update for naproxen or loratadine with Neulasta in bone pain associated with stage I-III breast cancer; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Loratadine (Loratadine)
• NEULASTA (pegfilgrastim)
• Naproxen (Naproxen)

Snippet

Sponsor: Amgen | Conditions: Bone Pain in Stage I - III Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-03-09